Immunology and Reproduction

Yen and Jaffe's Reproductive Endocrinology: Seventh Edition

Volumn , Issue , 2013, Pages 287-307

  Kutteh, William Hannah ^a,b   Stovall, Dale W ^c,d   Schust, Danny J ^e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Fertility Associates of Memphis   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Riverside Regional Medical Center   (United States)

^e University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903221787     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-2758-2.00014-7     Document Type: Chapter

References (146)

1. Hassold T.J. A cytogenetic study of repeated spontaneous abortions. Am J Hum Genet 1980, 32(5):723-730.
2. Ogasawara M., Aoki K., Okada S., et al. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000, 73(2):300-304.
3. Stephenson M.D., Awartani K.A., Robinson W.P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod 2002, 17(2):446-451.
4. Moffett A., Loke C. Implantation, embryo-maternal interactions, immunology and modulation of the uterine environment-a workshop report. Placenta 2006, 27(Suppl A):S54-S55.
5. Yoshinaga K. Review of factors essential for blastocyst implantation for their modulating effects on the maternal immune system. Semin Cell Dev Biol 2008, 19(2):161-169.
6. Campbell D.J., Koch M.A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011, 11(2):119-130.
7. Hsieh C.S., Lee H.M., Lio C.W. Selection of regulatory T cells in the thymus. Nat Rev Immunol 2012, 12(3):157-167.
8. B Cell Activation and Antibody Production: Cellular and Molecular Immunology. Cellular and Molecular Immunology 2012, 243-268. Elsevier/Saunders, Philadelphia. A.K. Abbas, A.H. Lichtman, S. Pillai (Eds.).
9. Sun J.C., Lanier L.L. NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat Rev Immunol 2011, 11(10):645-657.
10. Cells and Tissues of the Immune System: Cellular and Molecular Immunology. Cellular and Molecular Immunology 2012, 15-36. Elsevier/Saunders, Philadelphia. A.K. Abbas, A.H. Lichtman, S. Pillai (Eds.).
11. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
12. Oikonomopoulou K., Ricklin D., Ward P.A., et al. Interactions between coagulation and complement-their role in inflammation. Semin Immunopathol 2012, 34(1):151-165.
13. Zygmunt B., Veldhoen M. T helper cell differentiation more than just cytokines. Adv Immunol 2011, 109:159-196.
14. Hirahara K., Vahedi G., Ghoreschi K., et al. Helper T-cell differentiation and plasticity: insights from epigenetics. Immunology 2011, 134(3):235-245.
15. Weiner H.L. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 2001, 3(11):947-954.
16. Mucida D., Cheroutre H. The many face-lifts of CD4 T helper cells. Adv Immunol 2010, 107:139-152.
17. Cosmi L., Liotta F., Maggi E., et al. Th17 cells: new players in asthma pathogenesis. Allergy 2011, 66(8):989-998.
18. Willart M., Hammad H. Lung dendritic cell-epithelial cell crosstalk in Th2 responses to allergens. Curr Opin Immunol 2011, 23(6):772-777.
19. Hudson A.W., Ploegh H.L. The cell biology of antigen presentation. Exp Cell Res 2002, 272(1):1-7.
20. Durkin H.G., Waksman B.H. Thymus and tolerance. Is regulation the major function of the thymus?. Immunol Rev 2001, 182:33-57.
21. Pawlowski T.J., Staerz U.D. Thymic education-T cells do it for themselves. Immunol Today 1994, 15(5):205-209.
22. Orr M.T., Lanier L.L. Natural killer cell education and tolerance. Cell 2010, 142(6):847-856.
23. Kutteh W.H., Moldoveanu Z., Mestecky J. Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998, 14(Suppl 1):S51-S55.
24. Kutteh W.H., Koopman W.J., Conley M.E., et al. Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J Exp Med 1980, 152(5):1424-1429.
25. Kutteh W.H., Mestecky J. Secretory immunity in the female reproductive tract. Am J Reprod Immunol 1994, 31(1):40-46.
26. Mestecky J., Alexander R.C., Wei Q., et al. Methods for evaluation of humoral immune responses in human genital tract secretions. Am J Reprod Immunol 2011, 65(3):361-367.
27. Africander D., Louw R., Verhoog N., et al. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract. Contraception 2011, 84(4):423-435.
28. Buckner L.R., Schust D.J., Ding J., et al. Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix. J Reprod Immunol 2011, 92(1-2):8-20.
29. Wira C.R., Fahey J.V., Ghosh M., et al. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol 2010, 63(6):544-565.
30. Lachapelle M.H., Miron P., Hemmings R., et al. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996, 156(10):4027-4034.
31. Givan A.L., White H.D., Stern J.E., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997, 38(5):350-359.
32. Billingham R.E., Brent L., Medawar P.B. Actively acquired tolerance of foreign cells. Nature 1953, 172(4379):603-606.
33. Nagamatsu T., Schust D.J. The Role of Intrauterine Immune Privilege in Perinatal Infectious Diseases. Infection, Immune Homeostasis and Immune Privilege 2012, 12-39. Springer Basel, Basel, Switzerland. J. Stein-Streilein (Ed.).
34. Boyson J.E., Rybalov B., Koopman L.A., et al. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A 2002, 99(21):13741-13746.
35. Boyson J.E., Aktan I., Barkhuff D.A., et al. NKT cells at the maternal-fetal interface. Immunol Invest 2008, 37(5):565-582.
36. Male V., Trundley A., Gardner L., et al. Natural killer cells in human pregnancy. Methods Mol Biol 2010, 612:447-463.
37. Chazara O., Xiong S., Moffett A. Maternal KIR and fetal HLA-C: a fine balance. J Leukoc Biol 2011, 90(4):703-716.
38. Kopcow H.D., Allan D.S., Chen X., et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci U S A 2005, 102(43):15563-15568.
39. Manaster I., Mizrahi S., Goldman-Wohl D., et al. Endometrial NK cells are special immature cells that await pregnancy. J Immunol 2008, 181(3):1869-1876.
40. Nagamatsu T., Schust D.J. The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod Sci 2010, 17(3):209-218.
41. Fan D.X., Duan J., Li M.Q., et al. The decidual gamma-delta T cells up-regulate the biological functions of trophoblasts via IL-10 secretion in early human pregnancy. Clin Immunol 2011, 141(3):284-292.
42. Chen J.R., Cheng J.G., Shatzer T., et al. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 2000, 141(12):4365-4372.
43. Robb L., Li R., Hartley L., et al. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 1998, 4(3):303-308.
44. Dimitriadis E., Menkhorst E., Salamonsen L.A., et al. Review: LIF and IL11 in trophoblast-endometrial interactions during the establishment of pregnancy. Placenta 2010, 31(Suppl):S99-104.
45. Hill J.A., Polgar K., Harlow B.L., et al. Evidence of embryo- and trophoblast-toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1992, 166(4):1044-1052.
46. Yamada H., Polgar K., Hill J.A. Cell-mediated immunity to trophoblast antigens in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1994, 170(5 Pt 1):1339-1344.
47. Hill J.A., Haimovici F., Anderson D.J. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol 1987, 139(7):2250-2254.
48. King A., Burrows T.D., Hiby S.E., et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000, 21(4):376-387.
49. Kovats S., Main E.K., Librach C., et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248(4952):220-223.
50. Wei X.H., Orr H.T. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum Immunol 1990, 29(2):131-142.
51. Red-Horse K., Zhou Y., Genbacev O., et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004, 114(6):744-754.
52. Pennington K.A., Schlitt J.M., Jackson D.L., et al. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech 2012, 5(1):9-18.
53. Roberts R.M., Fisher S.J. Trophoblast stem cells. Biol Reprod 2011, 84(3):412-421.
54. Dahl M., Hviid T.V. Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Hum Reprod Update 2012, 18(1):92-109.
55. Huddleston H., Schust D.J. Immune interactions at the maternal-fetal interface: a focus on antigen presentation. Am J Reprod Immunol 2004, 51(4):283-289.
56. Furman M.H., Ploegh H.L., Schust D.J. Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface?. Hum Immunol 2000, 61(11):1169-1176.
57. Hunt J.S. Stranger in a strange land. Immunol Rev 2006, 213:36-47.
58. Li C., Houser B.L., Nicotra M.L., et al. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci U S A 2009, 106(14):5767-5772.
59. Parham P., Norman P.J., Abi-Rached L., et al. Review: immunogenetics of human placentation. Placenta 2012, 33(Suppl):S71-S80.
60. Kanai T., Fujii T., Unno N., et al. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol 2001, 45(2):94-99.
61. Lim K.H., Zhou Y., Janatpour M., et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997, 151(6):1809-1818.
62. Madeja Z., Yadi H., Apps R., et al. Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci U S A 2011, 108(10):4012-4017.
63. Trowsdale J., Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol 2008, 20(6):317-320.
64. Kuipers J.G., Bialowons A., Dollmann P., et al. The genetically-engineered secretory B27/Q10 chimeric molecule inhibits HLA-B27 restricted alloreactive T-lymphocytes. Clin Exp Rheumatol 2002, 20(4):455-462.
65. Laird S.M., Mariee N., Wei L., et al. Measurements of CD56+ cells in peripheral blood and endometrium by flow cytometry and immunohistochemical staining in situ. Hum Reprod 2011, 26(6):1331-1337.
66. Campbell K.S., Purdy A.K. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 2011, 132(3):315-325.
67. Carrington M., Martin M.P. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 2006, 298:225-257.
68. Faridi R.M., Das V., Tripthi G., et al. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum Reprod 2009, 24(7):1758-1764.
69. Erlebacher A., Vencato D., Price K.A., et al. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest 2007, 117(5):1399-1411.
70. Tafuri A., Alferink J., Moller P., et al. T cell awareness of paternal alloantigens during pregnancy. Science 1995, 270(5236):630-633.
71. Bermas B.L., Hill J.A. Proliferative responses to recall antigens are associated with pregnancy outcome in women with a history of recurrent spontaneous abortion. J Clin Invest 1997, 100(6):1330-1334.
72. Jackson D.L., Schust D.J. The Role of the Placenta in Autoimmune Disease and Early Pregnancy Loss. The Placenta: From Development to Disease 2011, 215-221. Wiley-Blackwell, Hoboken, NJ. H.H. Kay, D.M. Nelson, Y. Wang (Eds.).
73. Vargas-Villavicencio J.A., De Leon-Nava M.A., Morales-Montor J. Immunoendocrine mechanisms associated with resistance or susceptibility to parasitic diseases during pregnancy. Neuroimmunomodulation 2009, 16(2):114-121.
74. Oertelt-Prigione S. The influence of sex and gender on the immune response. Autoimmun Rev 2012, 11(6-7):A479-A485.
75. Cutolo M., Capellino S., Sulli A., et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci 2006, 1089:538-547.
76. Tanriverdi F., Silveira L.F., MacColl G.S., et al. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 2003, 176(3):293-304.
77. Yu-Lee L.Y. Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 2002, 57:435-455.
78. Runnebaum B., Stober I., Zander J. Progesterone, 20 alpha-dihydroprogesterone and 20 beta-dihydroprogesterone in mother and child at birth. Acta Endocrinol (Copenh) 1975, 80(3):569-576.
79. Beagley KW.,Gockel C.M. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003, 38(1):13-22.
80. Schust D.J., Anderson D.J., Hill J.A. Progesterone-induced immunosuppression is not mediated through the progesterone receptor. Hum Reprod 1996, 11(5):980-985.
81. Ehring G.R., Kerschbaum H.H., Eder C., et al. A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes. J Exp Med 1998, 188(9):1593-1602.
82. Gregory M.S., Duffner L.A., Faunce D.E., et al. Estrogen mediates the sex difference in post-burn immunosuppression. J Endocrinol 2000, 164(2):129-138.
83. Muller V., Szabo A., Viklicky O., et al. Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int 1999, 55(5):2011-2020.
84. Walker A.M. Unmodified and phosphorylated prolactin and gamma delta T cell development and function. Lupus 2001, 10(10):735-741.
85. Schumacher A., Brachwitz N., Sohr S., et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol 2009, 182(9):5488-5497.
86. Wilczynski J.R., Radwan M., Kalinka J. The characterization and role of regulatory T cells in immune reactions. Front Biosci 2008, 13:2266-2274.
87. Mellor A.L., Munn D.H. Extinguishing maternal immune responses during pregnancy: implications for immunosuppression. Semin Immunol 2001, 13(4):213-218.
88. Hill J.A., Polgar K., Anderson D.J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995, 273(24):1933-1936.
89. Tang A.W., Alfirevic Z., Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod 2011, 26(8):1971-1980.
90. Laird S.M., Tuckerman E.M., Cork B.A., et al. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003, 9(2):163-174.
91. Schust D.J., Hill J.A. Correlation of serum cytokine and adhesion molecule determinations with pregnancy outcome. J Soc Gynecol Investig 1996, 3(5):259-261.
92. Ober C.L., Martin A.O., Simpson J.L., et al. Shared HLA antigens and reproductive performance among Hutterites. Am J Hum Genet 1983, 35(5):994-1004.
93. Ober C., Hyslop T., Elias S., et al. Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study. Hum Reprod 1998, 13(1):33-38.
94. Stephenson M.D., Kutteh W.H., Purkiss S., et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010, 25(9):2203-2209.
95. Gough SC, Simmonds M.J. The HLA region and autoimmune disease: associations and mechanisms of action. Curr Genomics 2007, 8(7):453-465.
96. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4(2):295-306.
97. Stephenson M., Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol 2007, 50(1):132-145.
98. Jaslow C.R., Carney J.L., Kutteh W.H. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2010, 93(4):1234-1243.
99. Cervera R., Balasch J. Autoimmunity and recurrent pregnancy losses. Clin Rev Allergy Immunol 2010, 39(3):148-152.
100. Ernest J.M., Marshburn P.B., Kutteh W.H. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Semin Reprod Med 2011, 29(6):522-539.
101. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174(5):1584-1589.
102. Ziakas P.D., Pavlou M., Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010, 115(6):1256-1262.
103. Kaandorp S., Di Nisio M., Goddijn M., et al. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2009, 1:CD004734.
104. Kaandorp S.P., Goddijn M., van der Post J.A., et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010, 362(17):1586-1596.
105. Sauer R., Roussev R., Jeyendran R.S., et al. Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure. Fertil Steril 2010, 93(7):2441-2443.
106. Practice Committee of the American Society for Reproductive Medicine Anti-phospholipid Antibodies do not affect IVF success. Fertil Steril 2008, 90:S172-S173.
107. Kutteh W.H., Yetman D.L., Carr A.C., et al. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999, 71(5):843-848.
108. Poppe K., Velkeniers B., Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab 2008, 4(7):394-405.
109. Negro R., Schwartz A., Gismondi R., et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010, 95(9):E44-E48.
110. Esplin M.S., Branch D.W., Silver R., et al. Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 1998, 179(6 Pt 1):1583-1586.
111. Rushworth F.H., Backos M., Rai R., et al. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod 2000, 15(7):1637-1639.
112. Kutteh W.H., Schoolcraft W.B., Scott R.T. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum Reprod 1999, 14(11):2886-2890.
113. Turi A., Giannubilo S.R., Zanconi S., et al. Preconception steroid treatment in infertile women with antithyroid autoimmunity undergoing ovarian stimulation and intrauterine insemination: a double-blind, randomized, prospective cohort study. Clin Ther 2010, 32(14):2415-2421.
114. Cheng M.H., Nelson L.M. Mechanisms and models of immune tolerance breakdown in the ovary. Semin Reprod Med 2011, 29(4):308-316.
115. Pires E.S. Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update. J Assist Reprod Genet 2010, 27(9-10):519-524.
116. Kahaly G.J. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009, 161(1):11-20.
117. Akirav E.M., Ruddle N.H., Herold K.C. The role of AIRE in human autoimmune disease. Nat Rev Endocrinol 2011, 7(1):25-33.
118. Michels A.W., Gottlieb P.A. Autoimmune polyglandular syndromes. Nat Rev Endocrinol 2010, 6(5):270-277.
119. Reato G., Morlin L., Chen S., et al. Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab 2011, 96(8):E1255-E1261.
120. Bakalov V.K., Vanderhoof V.H., Bondy C.A., et al. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002, 17(8):2096-2100.
121. Nelson L.M. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009, 360(6):606-614.
122. Knauff E.A., Eijkemans M.J., Lambalk C.B., et al. Anti-mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 2009, 94(3):786-792.
123. Kutteh W.H. Immunology of multiple endocrinopathies associated with premature ovarian failure. The Endocrinologist 1996, 6:462-466.
124. Hoek A., Schoemaker J., Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997, 18(1):107-134.
125. Bachelot A., Rouxel A., Massin N., et al. Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure. Eur J Endocrinol 2009, 161(1):179-187.
126. Bidet M., Bachelot A., Bissauge E., et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011, 96(12):3864-3872.
127. Clarke G.N. Etiology of sperm immunity in women. Fertil Steril 2009, 91(2):639-643.
128. Marshburn P.B., Kutteh W.H. The role of antisperm antibodies in infertility. Fertil Steril 1994, 61(5):799-811.
129. Collin P., Kaukinen K., Valimaki M., et al. Endocrinological disorders and celiac disease. Endocr Rev 2002, 23(4):464-483.
130. Green P.H., Cellier C. Celiac disease. N Engl J Med 2007, 357(17):1731-1743.
131. Ticconi C., Rotondi F., Veglia M., et al. Antinuclear autoantibodies in women with recurrent pregnancy loss. Am J Reprod Immunol 2010, 64(6):384-392.
132. Brucato A., Cimaz R., Caporali R., et al. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol 2011, 40(1):27-41.
133. Laskin C.A., Bombardier C., Hannah M.E., et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997, 337(3):148-153.
134. Khoufache K., Michaud N., Harir N., et al. Anomalies in the inflammatory response in endometriosis and possible consequences: a review. Minerva Endocrinol 2012, 37(1):75-92.
135. Christodoulakos G., Augoulea A., Lambrinoudaki I., et al. Pathogenesis of endometriosis: the role of defective 'immunosurveillance'. Eur J Contracept Reprod Health Care 2007, 12(3):194-202.
136. Fukuda M.N., Sugihara K. An integrated view of L-selectin and trophinin function in human embryo implantation. J Obstet Gynaecol Res 2008, 34(2):129-136.
137. Ernest J.M., Marshburn P.B., Kutteh W.H. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Semin Reprod Med 2011, 29:522-539.
138. Jackson D.L., Schust D.J. The Role of the Placenta in Autoimmune Disease and Early Pregnancy Loss. The Placenta: From Development to Disease 2011, 215-221. Wiley-Blackwell, Hoboken, NJ. H.H. Kay, D.M. Nelson, Y. Wang (Eds.).
139. Koga K., Mor G. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol 2010, 63(6):587-600.
140. Kutteh W.H., Mestecky J., Wira C.R. Mucosal Immunity in the Human Female Reproductive Tract. Mucosal Immunology 2005, 95. Elsevier Academic Press, Burlington, MA, 1631-1646. ed 3. J. Mestecky, M.E. Lamm, J.R. McGhee (Eds.).
141. Nagamatsu T., Schust D.J. The Role of Intrauterine Immune Privilege in Perinatal Infectious Diseases. Infection, Immune Homeostasis and Immune Privilege 2012, 12-39. Springer Basel, Basel, Switzerland. J. Stein-Streilein (Ed.).
142. Nagamatsu T., Schust D.J. The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod Sci. 2010, 17:209-218.
143. Nelson L.M. Clinical practice. Primary ovarian insufficiency. New England J Medicine 2009, 360:606-614.
144. Red-Horse K., et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004, 114. 744-574.
145. Roberts R.M., Fisher S.J. Trophoblast stem cells. Biol Reprod 2011, 84:412-421.
146. Stephenson M., Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol 2007, 50:132-145.